Гиалуроновая кислота в коррекции генитоуринарного менопаузального синдрома у женщин после противо­опухолевого лечения

1. Harten I.A., Evanko S.P., Choe C.H., Lee E.W., Patel B.N., Bogdani M. et al. The extracellular matrix molecules versican and hyaluronan in urethral and vaginal tissues in stress urinary incontinence. Neurourol. Urodyn. 2021; 40(3): 771-82. https://dx.doi.org/10.1002/nau.24635
2. Abatangelo G., Vindigni V., Avruscio G., Pandis L., Brun P. Hyaluronic acid: redefining its role. Cells. 2020; 9(7): 1743. https://dx.doi.org/10.3390/cells9071743
3. Faubion S.S., Larkin L.C., Stuenkel C.A., Bachmann G.A., Chism L.A., Kagan R. et al. Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North american menopause society and the International society for the study of women's sexual health. Menopause. 2018; 25(6): 596-608. https://dx.doi.org/10.1097/GME.0000000000001121
4. Sarmento A., Lírio J.F., Medeiros K.S., Marconi C., Costa A.P.F., Crispim J.C. et al. Physical methods for the treatment of genitourinary syndrome of menopause: a systematic review. Int. J. Gynaecol. Obs. 2021; 153(2):200-19. https://dx.doi.org/10.1002/ijgo.13561
5. The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27(9): 976-92. https://dx.doi.org/10.1097/GME.0000000000001609
6. Agrawal S., LaPier Z., Nagpal S., Oot A., Friedman S., Hade E.M. et al. A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Menopause. 2024; 31(9): 750-5. https://dx.doi.org/10.1097/GME.0000000000002390
7. Donders G.G.G., Ruban K., Bellen G., Grinceviciene S. Pharmacotherapy for the treatment of vaginal atrophy. Expert Opin. Pharmacother. 2019; 20(7): 821-35. https://dx.doi.org/10.1080/14656566.2019.1574752
8. Cascone S., Lamberti G. Hydrogel-based commercial products for biomedical applications: a review. Int. J. Pharm. 2020; 573: 118803. https://dx.doi.org/10.1016/j.ijpharm.2019.118803
9. Sánchez-Prieto M., Pingarrón C., Bergamaschi L., Bermúdez J.C., Subiris González J., Sánchez Sánchez R. et al. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia. Gynecol. Endocrinol. 2024; 40(1): 2317268. https://dx.doi.org/10.1080/09513590.2024.2317268
10. De Seta F., Caruso S., Di Lorenzo G., Romano F., Mirandola M., Nappi R.E. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study. Maturitas. 2021; 147: 34-40. https://dx.doi.org/10.1016/j.maturitas.2021.03.002
11. Origoni M., Cimmino C., Carminati G., Iachini E., Stefani C., Girardelli S. et al. Postmenopausal vulvovaginal atrophy (VVA) is positively improved by topical hyaluronic acid application. A prospective, observational study. Eur. Rev. Med. Pharm. Sci. 2016; 20(20): 4190-5.
12. Grimaldi E.F., Restaino S., Inglese S., Foltran L., Sorz A., Di Lorenzo G. et al. Role of high molecular weight hyaluronic acid in postmenopausal vaginal discomfort. Minerva Ginecol. 2012; 64(4): 321-9.
13. Ekin M., Yaşar L., Savan K., Temur M., Uhri M., Gencer I. et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch. Gynecol. Obstet. 2011; 283(3): 539-43. https://dx.doi.org/10.1007/s00404-010-1382-8
14. Chen J., Geng L., Song X., Li H., Giordan N., Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial. J. Sex. Med. 2013; 10(6): 1575-84. https://dx.doi.org/10.1111/jsm.12125
15. Jokar A., Davari T., Asadi N., Ahmadi F., Foruhari S. Comparison of the hyaluronic acid vaginal cream and conjugated estrogen used in treatment of vaginal atrophy of menopause women: a randomized controlled clinical trial. Int. J. Community Based Nurs. Midwifery. 2016; 4(1): 69-78.
16. Duque-Estrada E. de O., Rosa V.P., Mosca M.M., do Nascimento H.L. Perceived efficacy of vaginal dryness relief: a comparative clinical study between sodium hyaluronate vaginal gel1 vs. promestriene cream. Adv. Sex. Med. 2017; 7: 34-43. https://dx.doi.org/10.4236/asm.2017.71003
17. Dos Santos C.C.M., Uggioni M.L.R., Colonetti T., Colonetti L., Grande A.J., Da Rosa M.I. Hyaluronic acid in postmenopause vaginal atrophy: a systematic review. J. Sex. Med. 2021; 18(1): 156-66. https://dx.doi.org/10.1016/j.jsxm.2020.10.016
18. Крикунова Л.И., Мкртчян Л.С., Галкин В.Н., Алексеева Г.С., Горбушин Н.Г. Способ лечения атрофического вагинита. Патент № RU 2646453 C1 Российская Федерация. Год публикации: 2018. Номер заявки: 2017104744. Дата регистрации: 15.02.2017. Дата публикации: 05.03.2018. Патентообладатель: ФГБУ "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации.
19. Казакова С.Н., Аполихина И.А., Тетерина Т.А., Бычкова А.Е., Саидова А.С. Лечение генитоуринарного менопаузального синдрома препаратом на основе гиалуроновой кислоты. Женское здоровье и репродукция. 2024; 2(63).
20. Garavaglia E., Sala C., Busato M., Bellia G., Tamburlin N., Massirone A. First use of thermal stabilized hyaluronic acid injection in one-year follow-up patients with genitourinary syndrome. Med. Devices (Auckl.). 2020; 13: 399-410. https://dx.doi.org/10.2147/MDER.S275966
21. Berreni N., Salerno J., Chevalier T., Alonso S., Mares P. Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study. BMC Womens Health. 2021; 21(1): 322. https://dx.doi.org/10.1186/s12905-021-01435-w
22. González I.P., Leibaschoff G., Esposito C., Cipolla G., Bader A., Lotti T. et al. Genitourinary syndrome of menopause and the role of biostimulation with noncross-linked injectable hyaluronic acid plus calcium hydroxyapatite. J. Biol. Regul. Homeost. Agents. 2019; 33(6): 1961-6. https://dx.doi.org/10.23812/19-251-L
23. Саидова А.С., Дудкина А.Р., Тетерина Т.А., Аполихина И.А. Эффективность интимной биоревитализации в терапии симптомов вульвовагинальной атрофии. Фарматека. 2023; 4-5: 96-103.
24. González-Isaza P., Sánchez-Prieto M., Sánchez-Borrego R. Chronic vulvar fissure: approach with cross-linked hyaluronic acid. Int. Urogynecol. J. 2023; 34(7): 1495-9. https://dx.doi.org/10.1007/s00192-022-05401-4
25. Moccia F., Pentangelo P., Ceccaroni A., Raffone A., Losco L., Alfano C. Injection treatments for vulvovaginal atrophy of menopause: a systematic review. Aesthetic Plast. Surg. 2023; 47(6): 2788-99. https://dx.doi.org/10.1007/s00266-023-03550-5
26. Buzzaccarini G., Marin L., Noventa M., Vitagliano A., Riva A., Dessole F. et al. Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review. Climacteric. 2021; 24(6): 560-71.https://dx.doi.org/10.1080/13697137.2021.1898580
27. Carter J., Baser R.E., Goldfrank D.J., Seidel B., Milli L., Stabile C. et al. A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors. Support. Care Cancer. 2021; 29(1): 311-22. https://dx.doi.org/10.1007/s00520-020-05472-3
28. Advani P., Brewster A.M., Baum G.P., Schover L.R. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy. J. Cancer Surviv. 2017; 11(4): 477-85. https://dx.doi.org/10.1007/s11764-017-0606-3
29. Massarotti C., Asinaro G., Schiaffino M.G., Ronzini C., Vacca I., Lambertini M. et al. Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors. Climacteric. 2023; 26(2): 129-34. https://dx.doi.org/10.1080/13697137.2023.2167596
30. Hersant B., SidAhmed-Mezi M., Belkacemi Y., Darmon F., Bastuji-Garin S., Werkoff G. et al. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study. Menopause. 2018; 25(10): 1124-30. https://dx.doi.org/10.1097/GME.0000000000001122
31. Bogliatto F., Leidi L., Miletta M. Hyaluronic acid injection as functional adjuvant therapy in menopausal vulvovaginal symptoms - preliminary report. Working Paper of Public Health. 2006; 5(1): 1-4. https://dx.doi.org/10.4081/wpph.2016.6694
32. Delia P., Sansotta G, Pontorieroet A, Iati G., De Salvo S., Pisana M. et al. Clinical evaluation of low-molecular-weight hyaluronic acid-based treatment on onset of acute side effects in women receiving adjuvant radiotherapy after cervical surgery: a randomized clinical trial. Oncol. Res. Treat. 2019; 42(4): 217-23. https://dx.doi.org/10.1159/000496036
33. Dinicola S., Pasta V., Costantino D., Guaraldi C., Bizzarri M. Hyaluronic acid and vitamins are effective in reducing vaginal atrophy in women receiving radiotherapy. Minerva Ginecol. 2015; 67(6): 523-31.
34. Мкртчян Л.С., Иванов С.А., Кулиева Г.З.К., Замулаева И.А., Крикунова Л.И. Улучшение качества жизни больных раком шейки матки после лучевой и химиолучевой терапии. Радиация и риск. 2020; 29(1): 120-8.
35. Бычкова А.Е., Аполихина И.А., Мкртчян Л.С. Коррекция атрофических изменений у онкологических больных после радикального лечения. В кн.: Перспективные направления в онкологии, радиологии и радиобиологии. Материалы IX конференции молодых ученых, посвященной памяти академика А.Ф. Цыба. Обнинск; 2023: 21-2.
36. Cosentino D., Piro F. Hyaluronic acid for treatment of the radiation therapy side effects: a systematic review. Eur. Rev. Med. Pharmacol. Sci. 2018;22(21): 7562-72. https://dx.doi.org/10.26355/eurrev_201811_16298
37. Ribeiro L.D.S., Silveira R.C.C.P., Vasques C.I., de Menêses A.G., Dos Reis P.E.D., Ferreira E.B. Hyaluronic acid to manage radiotoxicities in gynecological cancer patients: a scoping review. Support Care Cancer. 2024; 32(7): 439. https://dx.doi.org/10.1007/s00520-024-08614-z

Поступила 15.07.2025

Принята в печать 16.10.2025